好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2008 Annual Meeting | Emergency Neurology

Monday 04/14/08
09:00 AM - 12:45 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
AM Half-Day Course
Karen L. Roos, MD, FAAN
Critical Care
Participants will be well prepared to care for patients with myelopathies, headache, coma, and movement disorders in the emergency department and the ICU.
No CME available
Patient Care & Procedural Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement
Advanced
Practitioner, Fellow, Academician, Resident
Event Timeline
09:00 AM - 09:45 AM Acute Compressive and Noncompressive Myelopathies
Brian G. Weinshenker, MD, FAAN
09:55 AM - 10:40 AM Evaluation and Management of Headache in the Emergency Department
Todd D. Rozen, MD, FAAN
10:40 AM - 11:00 AM Break
11:00 AM - 11:45 AM Coma
Jerome B. Posner, MD, FAAN
11:55 AM - 12:45 PM Movement Disorder Emergencies
Robert L. Rodnitzky, MD, FAAN
Faculty Disclosures
Jerome B. Posner, MD, FAAN No disclosure on file
Robert L. Rodnitzky, MD, FAAN No disclosure on file
Karen L. Roos, MD, FAAN No disclosure on file
Brian G. Weinshenker, MD, FAAN Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Todd D. Rozen, MD, FAAN No disclosure on file